Back to top
more

Better trading starts here.

Brokerage Reports

Research for DVA

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

3 items in cart

View Cart/Checkout

DaVita Inc. [DVA]

Reports for Purchase

Showing records 161 - 180 ( 289 total )

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 161

12/04/2016

Industry Report

Pages: 11

Healthcare Facilities and Services: ACA Repeal and Replace - Lots of Noise, but Risks Appear Modest

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 162

11/04/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 163

11/02/2016

Daily Note

Pages: 7

3Q16 Conference Call Notes

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 164

11/02/2016

Company Report

Pages: 8

Trimming Estimates on DMG Outlook and Commercial Mix Headwinds

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 165

10/21/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 166

09/19/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 167

08/17/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 168

08/08/2016

Company Report

Pages: 8

Trimming Estimates on Further DMG (formerly HCP) Weakness

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 169

08/08/2016

Daily Note

Pages: 6

2Q16 Conference Call Notes

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 170

07/27/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 171

07/19/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 172

07/05/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 173

06/14/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 174

05/18/2016

Company Report

Pages: 10

Capital Markets Day Highlights ESA Opportunity and Long Turnaround Time at DMG

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 175

05/13/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 176

05/04/2016

Company Report

Pages: 8

Raising Estimates on Better than Expected Kidney Care

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 177

04/11/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 178

03/08/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 179

02/11/2016

Company Report

Pages: 8

Light Guidance, but Growth Should Improve Beyond 2016

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 180

02/02/2016

Company Report

Pages: 8

Price: 24.95